As the US Food and Drug Administration approved the new HIV drug dolutegravir on 13 Aug, Médecins Sans Frontières (MSF) questioned when people in developing countries would be able to access this promising new drug. Studies have shown dolutegravir, a drug from the potent new integrase inhibitor...
MSF pricing analysis also extends to HIV diagnostic and monitoring tools The price of first- and second-line antiretrovirals (ARVs) to treat HIV are falling because of increased competition among generic producers, but newer ARVs continue to be priced astronomically high, according to the annual...
Everyday, 600 children and 4,000 adults die of a treatable and manageable disease. After decades of struggle against HIV/AIDS there is still an urgent need to do more to stop people dying needlessly. Despite available and mostly affordable drugs, tools and models of care that work, is it acceptable...
This year the World AIDS Day theme remains the same as that of 2011, "Getting to zero: Zero new HIV infections. Zero discrimination. Zero AIDS related deaths". And the same, big question hangs over it: “Is this too ambitious?” The latest UNAIDS report [1] gives encouraging news that a 50% reduction...
South Sudan: a humanitarian crisis Uganda: Escaping conflict in Kivu Democratic Republic of Congo: Malaria outbreak Burkina Faso: malnutrition decrease Zimbabwe: HIV : from Washington to Harare
While new United Nations data pointing to gains made in the fight against HIV/AIDS is sparking optimism ahead of the 2012 International AIDS Conference in Washington, countries most affected by the pandemic continue to struggle to place enough people on treatment and to implement the best science...
MSF opens new HIV/AIDS clinic on India Myanmar border Last week, Médecins Sans Frontières （MSF） opened a new clinic in Moreh, a small rural town in Chandel district in the Indian state of Manipur that is on the border with Myanmar. The specialised clinic offers free medical treatment and...
In a report released today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar (1), highlights the critical need for increased HIV and Tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB), treatment in the country. According to the report, 85,000...
Médecins Sans Frontières (MSF) is alarmed by the situation of HIV/AIDS patients in the Democratic Republic of Congo (DRC), the lack of priority given by the Congolese authorities and the withdrawal of donors, all occurring as the Global Fund to Fight AIDS, Malaria and Tuberculosis prepares to...
“We handed over many treatment programmes in Latin America and Asia to local authorities in the confidence that they would be able to provide people with the treatment they needed to stay alive. Higher drug prices will create real funding challenges for some middle-income countries.” - Dr Tido VON...
